Biventricular dysfunction predicts mortality in ST elevation myocardial infarction patients with cardiogenic shock

Angga Dwi Prasetyo1, Hendry Purnasidha Bagaswoto2, Firandi Saputra1

  • 1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Jalan Farmako Sekip Utara, Yogyakarta, 55281, Indonesia.

Insights

Biventricular dysfunction significantly increases in-hospital mortality risk in ST-elevation myocardial infarction (STEMI) patients experiencing cardiogenic shock. Other mortality predictors include renal failure and vasopressor use.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Clinical Research

Background:

  • Mortality in cardiogenic shock due to ST-elevation myocardial infarction (STEMI) remains high despite reperfusion therapy.
  • Ventricular systolic dysfunction is a primary cause of cardiogenic shock in STEMI.
  • While left and right ventricular dysfunction have been studied, the predictive value of biventricular dysfunction for mortality is unclear.

Purpose of the Study:

  • To evaluate the mortality predictive value of biventricular systolic dysfunction in STEMI patients with cardiogenic shock.
  • To identify key predictors of in-hospital mortality in this patient population.

Main Methods:

  • Retrospective cohort study using the Sardjito Cardiovascular Intensive Care (SCIENCE) registry.
  • Data collected from November 2021 to September 2023 at Dr. Sardjito General Hospital.
  • Multivariate logistic regression analysis to assess predictors of in-hospital mortality.

Main Results:

  • Biventricular dysfunction (BVD) significantly increases the risk of in-hospital mortality (OR, 1.771; p=0.016).
  • Other significant mortality predictors include renal failure (OR, 5.122; p<0.001) and inotropic/vasopressor use (OR, 6.876; p<0.001).
  • Percutaneous coronary intervention (PCI) was associated with reduced mortality (OR, 0.493; p=0.044).

Conclusions:

  • Biventricular dysfunction is a significant independent predictor of in-hospital mortality in STEMI patients with cardiogenic shock.
  • Renal failure and the need for inotropic or vasopressor support are critical factors influencing mortality.
  • PCI may play a protective role in reducing mortality in this cohort.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
652
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
515